2509 POSTER Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme (GBM): preliminary results

✍ Scribed by C.M. Carapella; A. Felici; M.A. Mirri; A. Pace; M.A. Carosi; G. Metro; B. Jandolo; E. Occhipinti; F. Cognetti; A. Fabi

• Book ID: 118625754
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 57 KB
• Volume: 5
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(07)70912-6